Journal of Nuclear Cardiology

, Volume 24, Issue 1, pp 329–331 | Cite as

18F-fluoromisonidazole (FMISO) PET may have the potential to detect cardiac sarcoidosis

  • Osamu Manabe
  • Kenji Hirata
  • Okamoto Shozo
  • Tohru Shiga
  • Yuko Uchiyama
  • Kentaro Kobayashi
  • Shiro Watanabe
  • Takuya Toyonaga
  • Hisaya Kikuchi
  • Noriko Oyama-Manabe
  • Nagara Tamaki
Images That Teach

Abstract

18F-fluoromisonidazole (FMISO) is a positron emission tomography (PET) tracer that accumulates in hypoxic tissues. We here present a case of suspected cardiac sarcoidosis which was detected with increased FMISO uptake.

Keywords

FMISO FDG cardiac sarcoidosis inflammation 

Notes

Disclosure

The authors have indicated that they have no financial conflict of interest.

References

  1. 1.
    Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007;357:2153-65.CrossRefPubMedGoogle Scholar
  2. 2.
    Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014;11:1305-23.CrossRefPubMedGoogle Scholar
  3. 3.
    Manabe O, Ohira H, Yoshinaga K, Sato T, Klaipetch A, Oyama-Manabe N, et al. Elevated (18)F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis. Eur J Nucl Med Mol Imaging 2013;40:1558-66.CrossRefPubMedGoogle Scholar
  4. 4.
    Manabe O, Yoshinaga K, Ohira H, Masuda A, Sato T, Tsujino I, et al. The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis. J Nucl Cardiol 2016;23:244-52.CrossRefPubMedGoogle Scholar
  5. 5.
    Toyonaga T, Hirata K, Yamaguchi S, Hatanaka KC, Yuzawa S, Manabe O, et al. 18F-fluoromisonidazole positron emission tomography can predict pathological necrosis of brain tumors. Eur J Nucl Med Mol Imaging 2016.Google Scholar
  6. 6.
    Shelton ME, Dence CS, Hwang DR, Herrero P, Welch MJ, Bergmann SR. In vivo delineation of myocardial hypoxia during coronary occlusion using fluorine-18 fluoromisonidazole and positron emission tomography: A potential approach for identification of jeopardized myocardium. J Am Coll Cardiol 1990;16:477-85.CrossRefPubMedGoogle Scholar
  7. 7.
    Piotrowski WJ, Kiszałkiewicz J, Pastuszak-Lewandoska D, et al. Expression of HIF-1A/VEGF/ING-4 axis in pulmonary sarcoidosis. Adv Exp Med Biol 2015;866:61-9.CrossRefPubMedGoogle Scholar
  8. 8.
    Kawai N, Lin W, Cao WD, Ogawa D, Miyake K, Haba R, et al. Correlation between 18F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas. Eur J Nucl Med Mol Imaging 2014;41:1870-8.CrossRefPubMedGoogle Scholar

Copyright information

© American Society of Nuclear Cardiology 2016

Authors and Affiliations

  • Osamu Manabe
    • 1
  • Kenji Hirata
    • 1
  • Okamoto Shozo
    • 1
  • Tohru Shiga
    • 1
  • Yuko Uchiyama
    • 1
  • Kentaro Kobayashi
    • 1
  • Shiro Watanabe
    • 1
  • Takuya Toyonaga
    • 1
  • Hisaya Kikuchi
    • 1
  • Noriko Oyama-Manabe
    • 2
  • Nagara Tamaki
    • 1
  1. 1.Department of Nuclear MedicineHokkaido University Graduate School of MedicineSapporoJapan
  2. 2.Diagnostic and Interventional RadiologyHokkaido University HospitalSapporoJapan

Personalised recommendations